Endometriosis Trial, Recruiting NCT04151433 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT04151433
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 40 years old (inclusive)
  • You have an endometriotic cyst (a cyst caused by endometriosis) on one ovary only, measuring between 2.5 cm and 8 cm across
  • You have a smaller endometriosis-related cyst (2 cm or less) on the other ovary, if present
  • You are experiencing difficulty getting pregnant and/or pelvic pain
  • Your Body Mass Index (BMI) is 35 or below
  • You have been using contraception (combined pill or progestogen-only pill) for at least 4 weeks before surgery
  • You are planned to have keyhole surgery using a CO2 laser to treat your endometriosis cyst

Who may not be able to join:

  • Your pelvic surgery could not be fully completed
  • You have a medical reason why you cannot take contraception (combined or progestogen-only)
  • You are using or plan to use a type of hormone treatment called GnRH analogues before surgery or in the first 3 months after surgery
  • You have had, or are planned to have, your womb (uterus) removed
  • You have previously had one ovary removed
  • You have a condition affecting your pituitary gland or hypothalamus (glands in the brain that control hormones)
  • There is any concern that a cyst may be cancerous
  • You have an endometriosis cyst larger than 2 cm on the opposite ovary
  • Your AMH level (a blood test that measures ovarian reserve) is below 0.7 before surgery (confirm with trial site)
  • You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carla Tomassetti, MD, PhD, Leuven University Fertility Center

Phone: +3216340825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 October 2019
Est. completion
1 December 2024

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

AMH levels 3 months postoperatively

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov